Baird Financial Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,575
| Closed | -$2.02M | – | 1770 |
|
|
2024
Q1 | $2.02M | Buy |
+29,575
| New | +$2.02M | ﹤0.01% | 953 |
|
|
2022
Q3 | – | Sell |
-3,895
| Closed | -$236K | – | 1724 |
|
|
2022
Q2 | $236K | Buy |
+3,895
| New | +$236K | ﹤0.01% | 1644 |
|
|
2021
Q4 | – | Sell |
-2,538
| Closed | -$284K | – | 1886 |
|
|
2021
Q3 | $284K | Sell |
2,538
-331
| -12% | -$37K | ﹤0.01% | 1692 |
|
|
2021
Q2 | $464K | Sell |
2,869
-203
| -7% | -$32.8K | ﹤0.01% | 1421 |
|
|
2021
Q1 | $374K | Buy |
3,072
+1,080
| +54% | +$131K | ﹤0.01% | 1446 |
|
|
2020
Q4 | $305K | Buy |
+1,992
| New | +$305K | ﹤0.01% | 1376 |
|